Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pandemic Influenza
Research
NIAID is 'on the ball' with bird flu research, but gaps remain
Against a backdrop of low-volume but growing concerns about bird flu, the NIH's NIAID has laid out a plan to study the virus that causes the illness.
Helen Floersh
Jun 10, 2024 5:50am
Philanthropist puts up $171M to create pandemic antiviral center
Aug 31, 2022 9:45am
Janssen culls BARDA-funded flu phase 3 antiviral pimodivir
Sep 3, 2020 7:00am
